Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!
Top 5 New Entrants companies in Enzalutamide by Most Patent Filing In 5 Years in the United States in 2019
The Enzalutamide top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 5 Years Enzalutamide New Entrants in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Enzalutamide is used to treat men with a certain type of prostate cancer.